This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Neoplasm of the liver is an abnormal growth or tumor that is found in the liver. It can be benign (non-cancerous) or malignant (cancerous). Neoplasms of the liver can be caused by a variety of factors, including genetic predisposition, environmental exposures, and lifestyle habits. The most common types of neoplasms of the liver are hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and hemangioma. HCC is the most common primary liver cancer, and is often the result of chronic hepatitis B or C infections, alcohol abuse, non-alcoholic fatty liver disease, and cirrhosis. CCA is the most common bile duct cancer, and is often caused by bile duct obstruction, chronic inflammation, and cirrhosis. Hemangiomas are the most common benign liver tumors. They are usually asymptomatic, but can cause complications if they are large or located near major blood vessels. Diagnosis of neoplasms of the liver involves imaging tests such as computed tomography (CT) or magnetic resonance imaging (MRI) scans, as well as blood tests to check for abnormal levels of tumor markers. Treatment depends on the type, size, and location of the tumor, and may include surgery, chemotherapy, radiation therapy, or targeted therapy. Neoplasms of the liver can be serious and life-threatening. It is important for people with a family history of liver cancer to be aware of the risks and seek medical advice if they experience any symptoms. Early detection and treatment can improve the chances of successful treatment and improve the outlook for those affected.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States